Urinary excretion of viable podocytes in health and renal disease.
about
Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective studySecondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to GlomerulosclerosisInsights into kidney stem cell development and regeneration using zebrafishNew insights into the pathology of podocyte loss: mitotic catastropheMicroRNAs in Diabetic Kidney DiseaseRenal stem cells: fact or science fiction?Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatmentSpironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic ratsPodocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.Conditionally immortalized human podocyte cell lines established from urine.Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathiesA comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study.The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.Microplate-based platform for combined chromatin and DNA methylation immunoprecipitation assaysPodocyte injury and albuminuria in mice with podocyte-specific overexpression of the Ste20-like kinase, SLK.A pilot trial assessing urinary gene expression profiling with an mRNA array for diabetic nephropathy.Activation of NFAT signaling in podocytes causes glomerulosclerosis.Structural analysis of how podocytes detach from the glomerular basement membrane under hypertrophic stressDecreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsiaMessenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyAdvances in the biology and genetics of the podocytopathies: implications for diagnosis and therapyPathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injuryProgression of glomerular and tubular disease in pediatrics.Podocyturia: Is there any clinical utility?Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence.Urinary FSP1 is a biomarker of crescentic GNGenomic biomarkers for chronic kidney disease.Human Urine-Derived Renal Progenitors for Personalized Modeling of Genetic Kidney Disorders.Cell cycle re-entry sensitizes podocytes to injury induced death.Transmembrane TNF-α Facilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy.Protective effects of low-dose rapamycin combined with valsartan on podocytes of diabetic rats.Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patientsThe podocyte: from bench to bedside.Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry NephropathyGlomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarkerWilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuriaAlteration of podocyte phenotype in the urine of women with preeclampsia
P2860
Q24597867-4CEDBBAC-5B3F-490F-8422-49FF85DE52E0Q26752830-8FBE29C8-7C7B-419B-9D45-67B4EBC43E72Q26765261-8CB449B4-C7B5-458A-82EE-8D2DD0599A8EQ26991667-CEF75DF4-A861-4FAF-8B90-4624FF578040Q27002171-287A53A5-92FD-4D75-9D7A-A24FFBB95084Q27006064-A31124E7-2C20-4153-A7B9-D06EFDDAC7F5Q28481298-813DB1DE-CE12-42CD-97D1-DEFD101732D1Q28575620-786620FB-FA3C-43B1-9A31-4595228FF030Q30252343-0E1A1C4B-7E17-4049-A0C2-1FE07B0FD5BAQ33727877-2D267E68-B200-4936-AB91-8ECB4AC117AEQ33741426-BB8A1904-3A0C-4153-BFB7-CB4B0D142EEAQ33803050-14803D33-A1DE-4FF5-B7B3-526A09FF4E95Q33882317-29A07C62-E391-4B7C-9E9A-2550E6F156D6Q33974601-5C6D78E2-C38F-44FA-A929-FC8969588324Q34078513-4AC240FB-3961-43A6-BC97-8644A4F73024Q34254409-8A0DBBDA-5228-44BE-BA0C-0764F586D9D9Q34281503-8C0E4AF5-5DCC-4011-A423-2BCE2E525EE0Q34455455-D52E6A89-9EC4-4E91-B144-58D7E425A743Q34687329-503617D9-98F1-4CE0-A467-2B23C51F3A42Q34731351-9231CC78-C496-4645-A8F3-1726DED58ED0Q35011234-4E9A1632-9E9B-4F50-BDA5-A7A8ED8D4479Q35056271-AD66559C-A9CF-4D30-9E17-187DE41E48B1Q35070778-3F4D7EBF-1534-42AF-996D-F334E595ADADQ35130326-4F2E714F-70ED-4255-B349-A0BED9C60321Q35234337-D0B8AC8C-E9DD-43AC-B289-CB672B70A160Q35351182-CFA73993-8D0D-48AC-A972-ED7B27DE4665Q35592469-82C63CD8-8C93-45DF-AA7A-3AAE9D85DE7CQ35715722-5BFEE1BB-7479-426E-AF8B-2E8B7F72BB16Q35896442-EE1F1F75-B5C0-45EE-B5D1-6F92EF222FD7Q35903071-23CC0153-0A75-4ACC-B639-F953FC09BAA1Q36032309-D72C69E8-08B6-4A36-9DF3-C37BB8EE3E18Q36181815-FDD3E215-F5DD-4923-90F0-42F46D08FDD9Q36183003-C170EAA9-2EAD-458C-AFC8-AAD35813F95EQ36205618-931A5F88-893D-4D77-A97B-61C7BF0FE0D5Q36219510-5F983AE9-25AA-4086-A867-C0A0830A361BQ36228560-69132C01-297A-4E20-B07A-2F3023574F93Q36314908-4C8B8C46-93FF-4163-89F3-8AB3EE82A8FDQ36389219-95F62E3A-58C9-4A67-A5DA-23BD3B905CB1Q36721369-AC6ACDA7-3BF2-4CEA-8A0F-5C4799E57D4DQ36773959-69255F67-5733-444B-8718-2EC535DFCD3B
P2860
Urinary excretion of viable podocytes in health and renal disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Urinary excretion of viable podocytes in health and renal disease.
@ast
Urinary excretion of viable podocytes in health and renal disease.
@en
type
label
Urinary excretion of viable podocytes in health and renal disease.
@ast
Urinary excretion of viable podocytes in health and renal disease.
@en
prefLabel
Urinary excretion of viable podocytes in health and renal disease.
@ast
Urinary excretion of viable podocytes in health and renal disease.
@en
P2093
P2860
P1476
Urinary excretion of viable podocytes in health and renal disease.
@en
P2093
Bryan D Myers
Kevin V Lemley
Stefanie U Vogelmann
W James Nelson
P2860
P356
10.1152/AJPRENAL.00404.2002
P577
2003-03-11T00:00:00Z